Ambev expands beverage portfolio to meet shifting consumer habits

Ambev is expanding its product offerings in Brazil to meet changing consumer preferences for diverse beverage options. The company has invested over R$ 10 billion over the last three years in brewery modernization, technology, and product innovation.

A key focus is the company’s ‘Wellness’ portfolio, which includes non-alcoholic, gluten-free, and low-calorie options such as Budweiser Zero, Michelob Ultra, and Corona Cero. This segment saw a volume growth of approximately 60% in the second quarter of 2026 compared to the previous year.

Market data reflects this shift, with non-alcoholic beer's share of volume consumed in Brazil rising from 2.5% in 2024 to 3.9% in 2026. Ambev reported that its own category volumes grew by approximately 30% in 2025.